Correlation Between Agios Pharm and Y MAbs
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Y MAbs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Y MAbs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Y mAbs Therapeutics, you can compare the effects of market volatilities on Agios Pharm and Y MAbs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Y MAbs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Y MAbs.
Diversification Opportunities for Agios Pharm and Y MAbs
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Agios and YMAB is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Y mAbs Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Y mAbs Therapeutics and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Y MAbs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Y mAbs Therapeutics has no effect on the direction of Agios Pharm i.e., Agios Pharm and Y MAbs go up and down completely randomly.
Pair Corralation between Agios Pharm and Y MAbs
Given the investment horizon of 90 days Agios Pharm is expected to generate 0.75 times more return on investment than Y MAbs. However, Agios Pharm is 1.33 times less risky than Y MAbs. It trades about 0.38 of its potential returns per unit of risk. Y mAbs Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 4,487 in Agios Pharm on September 2, 2024 and sell it today you would earn a total of 1,452 from holding Agios Pharm or generate 32.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Y mAbs Therapeutics
Performance |
| Timeline |
| Agios Pharm |
| Y mAbs Therapeutics |
Agios Pharm and Y MAbs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Y MAbs
The main advantage of trading using opposite Agios Pharm and Y MAbs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Y MAbs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Y MAbs will offset losses from the drop in Y MAbs' long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Y MAbs vs. Revolution Medicines | Y MAbs vs. Black Diamond Therapeutics | Y MAbs vs. Passage Bio | Y MAbs vs. Bluebird bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |